EUR 306.0
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 5.02 Million EUR | -16.21% |
2022 | 5.99 Million EUR | 32.42% |
2021 | 4.52 Million EUR | 1157.43% |
2020 | -428.37 Thousand EUR | 20.78% |
2019 | -540.74 Thousand EUR | 41.69% |
2018 | -927.29 Thousand EUR | -29.49% |
2017 | -716.12 Thousand EUR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 2.21 Million EUR | 0.0% |
2023 FY | 5.02 Million EUR | -16.21% |
2023 Q2 | 1.8 Million EUR | 0.0% |
2023 Q4 | 3.22 Million EUR | 0.0% |
2022 Q2 | 2.97 Million EUR | 0.0% |
2022 FY | 5.99 Million EUR | 32.42% |
2022 Q4 | 3.02 Million EUR | 0.0% |
2021 FY | 4.52 Million EUR | 1157.43% |
2021 Q4 | 2.85 Million EUR | 0.0% |
2021 Q2 | 1.67 Million EUR | 0.0% |
2020 FY | -428.37 Thousand EUR | 20.78% |
2020 Q4 | 82.44 Thousand EUR | 0.0% |
2020 Q2 | -509.29 Thousand EUR | 0.0% |
2019 Q4 | -175.29 Thousand EUR | 0.0% |
2019 Q2 | -365.45 Thousand EUR | 0.0% |
2019 FY | -540.74 Thousand EUR | 41.69% |
2018 Q4 | -21.12 Thousand EUR | 0.0% |
2018 FY | -927.29 Thousand EUR | -29.49% |
2018 Q3 | -21.12 Thousand EUR | 95.23% |
2018 Q1 | -442.52 Thousand EUR | -91.03% |
2018 Q2 | -442.52 Thousand EUR | 0.0% |
2017 Q4 | -231.65 Thousand EUR | 0.0% |
2017 Q1 | -178.8 Thousand EUR | 0.0% |
2017 FY | -716.12 Thousand EUR | 0.0% |
2017 Q2 | -178.8 Thousand EUR | 0.0% |
2016 Q4 | -178.8 Thousand EUR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Fresenius Medical Care AG & Co. KGaA | 1.36 Billion EUR | 99.633% |
Fresenius SE & Co. KGaA | 1.14 Billion EUR | 99.56% |
M1 Kliniken AG | 15.69 Million EUR | 67.988% |
Maternus-Kliniken Aktiengesellschaft | -9.26 Million EUR | 154.275% |
MEDICLIN Aktiengesellschaft | 12.72 Million EUR | 60.494% |
RHÖN-KLINIKUM Aktiengesellschaft | 40.39 Million EUR | 87.559% |
VITA 34 AG | -3.12 Million EUR | 261.086% |